Caterpillar Files ITC Complaint Over Heavy Equipment Imports
Published Date: 5/29/2026
Notice
Summary
The U.S. International Trade Commission got a complaint from Caterpillar about some heavy machinery parts being imported and sold unfairly by Doosan Bobcat companies around the world. They want to stop these imports and sales while the case is reviewed, which could affect businesses and buyers soon. The public and other groups have a chance to share their thoughts before any decisions are made.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
Possible Ban on Imported Parts
A complaint filed May 26, 2026 (Docket No. 3910) asks the U.S. International Trade Commission to issue a limited exclusion order, cease and desist orders, and require a bond during the 60-day Presidential review period under 19 U.S.C. 1337(j). If the Commission grants those remedies, specified Doosan Bobcat heavy machinery and components named in the complaint could be barred from importation and sale in the United States during that review period.
Commission Seeks Input on Market and Safety Effects
The Commission specifically asks for comments on whether the requested relief would affect public health and welfare, competitive conditions in the U.S. economy, production of like or directly competitive articles in the United States, whether U.S. suppliers could replace the subject articles within a commercially reasonable time, and how U.S. consumers would be impacted.
Public Comment Opportunity and Deadlines
The Commission invites the public, interested parties, and government agencies to file written comments on public interest issues; submissions must be filed no later than close of business eight calendar days after the May 29, 2026 Federal Register publication and are limited to five (5) pages, inclusive of attachments. Complainant may file replies no later than three calendar days after initial submissions were due.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10647 — Tin Mill Products From China, Taiwan, and Turkey; Determinations
The U.S. government found that tin mill products from China, Taiwan, and Turkey might be hurting American businesses by being sold too cheaply or unfairly supported by foreign governments. They’re moving forward with a deeper investigation that could lead to new rules or tariffs to protect U.S. industries. If you’re involved in making or using these products, keep an eye out for updates that could affect prices and trade soon.
2026-10743 — Polypropylene Corrugated Boxes From Vietnam; Supplemental Schedule for the Final Phase of the Investigation
The U.S. International Trade Commission updated the timeline for its final review of polypropylene corrugated boxes from Vietnam. This affects importers and manufacturers as the investigation looks into unfair pricing and government subsidies. Key deadlines have shifted, so businesses should stay alert for possible duties or changes starting August 2026.
2026-10649 — Freight Rail Couplers and Parts Thereof From Czech Republic and India; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is wrapping up investigations into whether freight rail couplers from the Czech Republic and India are unfairly priced or subsidized, possibly hurting American businesses. If confirmed, extra duties could be added to these imports to protect U.S. manufacturers. This final phase started on May 6, 2026, and could impact prices and trade soon.
2026-10545 — Fine Denier Polyester Staple Fiber: Monitoring Developments in the Domestic Industry; Institution and Scheduling Notice for the Subject Investigation
The U.S. International Trade Commission is keeping a close eye on the fine denier polyester staple fiber industry after the President put limits on imports to protect American businesses. This monitoring helps decide if the current import rules, which started in late 2024 and last until 2028, are working well or need changes. If you’re in the fiber or textile world, expect updates that could affect trade and prices soon!
2026-10550 — Methylene Diphenyl Diisocyanate (MDI) From China; Determination
The U.S. has decided that imports of Methylene Diphenyl Diisocyanate (MDI) from China are hurting American companies because they're being sold at unfairly low prices. This means U.S. businesses like BASF and Dow Chemical, who make MDI here, get some protection. Expect new rules and possible extra costs on these imports starting soon to keep things fair.
2026-10405 — Citric Acid and Certain Citrate Salts From China; Determinations
The U.S. International Trade Commission decided to keep extra taxes on citric acid and certain citrate salts imported from China. This means American companies making these products are protected from unfair competition, helping them stay strong. The decision was finalized in May 2026 and signals that these duties will continue to impact prices and trade for the foreseeable future.
Previous / Next Documents
Previous: 2026-10672 — JPMorgan Public and Private Credit Fund, et al.
JPMorgan’s credit and tax-aware funds want to give investors more chances to sell their shares back every month, with limits on how much can be bought back over three months. This change could make it easier for investors to get their money out while keeping the funds stable. The SEC is reviewing this request and will decide by late June 2026 unless someone asks for a hearing.
Next: 2026-10674 — Advisory Committee; Psychopharmacologic Drugs Advisory Committee; Renewal
The FDA is renewing the Psychopharmacologic Drugs Advisory Committee for two more years, keeping it active until June 4, 2028. This committee helps make sure psychiatric drugs are safe and effective, affecting drug makers, doctors, and patients. No new costs or big changes, just a smooth continuation of expert advice to keep mental health treatments on track.